Strains
Limosilactobacillus reuteri
NOVI-51
L. reuteri is widely known for having a positive impact on infant health. In trial, NOVI-51 demonstrated improvement of infant colic in babies when consumed during the last trimester of pregnancy.
Benefits of NOVI-51:
-
Probiotic support for mom and baby
-
Helps prevent colic
-
Supports digestive health
-
Clinically proven to improve infant colic via prenatal administration
-
Being consumed by expectant mothers in the last trimester of pregnancy, NOVI-51 is effective from birth
-
Benefits have also been proven clinically significant for babies born via C-section
-
The low daily dosage allows for NOVI-51 to be easily incorporated into existing pre-natal formulations which include other vital nutrients for pregnant mothers
Clinical Dosage for NOVI-51:
0,1 billion CFU per day